See also this year's filing and all EDGAR filings for this company.
PDF Report 0001863127_2023_Tyra_Biosciences_Inc.pdf
Logs
Graph
Absolute values for 0001863127, Tyra Biosciences Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 257,288,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 1,077,000 |
3 | remainder_Assets | 7,816,000 |
4 | LiabilitiesCurrent | 5,701,000 |
5 | LiabilitiesNoncurrent | 2,651,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 15,919,000 |
9 | ResearchAndDevelopmentExpense | 43,008,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 3,602,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 266,181,000 |
1 | Liabilities | 8,352,000 |
2 | Expenses | 58,927,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 257,829,000 |
5 | NetIncome | -55,325,000 |
6 | ComprehensiveNetIncome | -55,325,000 |
7 | BaseVar | 168,531,000 |
8 | EconomicCapitalRatio | 2.83 |